Buyer Name: NHS Blood and Transplant
Buyer Address: 500 North Bristol Park, Bristol, UKK12, BS34 7QH, United Kingdom
Contact Email: rowena.thomas@nhsbt.nhs.uk
Buyer Name: NHS Blood and Transplant
Buyer Address: 500 North Bristol Park, Bristol, UKK12, BS34 7QH, United Kingdom
Contact Email: rowena.thomas@nhsbt.nhs.uk
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
No linked documents found for this notice.
External Link: https://www.find-tender.service.gov.uk/Notice/002096-2026
Link Description: Tender notice on Find a Tender
Lot 1 Status: active
Lot 1 Has Options: Yes
Lot 1 Options: One (1) year optional extension
Lot 1 Value: GBP 600,000.00
Lot 1 Value (Gross): GBP 660,000.00
Lot 1 Contract Start: 2026-04-01T00:00:00+01:00
Lot 1 Contract End: 2027-03-31T23:59:59+01:00
Lot 1 SME Suitable: Yes
Lot 1 Award Criterion (quality): Quality (30%)
Lot 1 Award Criterion (quality): Social Value (10%)
Lot 1 Award Criterion (price): Price (60%)
Document Description: Tender notice on Find a Tender
{
"buyer": {
"id": "GB-PPON-PDBY-6395-VWBP",
"name": "NHS Blood and Transplant"
},
"date": "2026-01-12T08:35:40Z",
"id": "002096-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-0514f8",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Bristol",
"postalCode": "BS34 7QH",
"region": "UKK12",
"streetAddress": "500 North Bristol Park"
},
"contactPoint": {
"email": "rowena.thomas@nhsbt.nhs.uk"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.nhsbt.nhs.uk/"
},
"id": "GB-PPON-PDBY-6395-VWBP",
"identifier": {
"id": "PDBY-6395-VWBP",
"scheme": "GB-PPON"
},
"name": "NHS Blood and Transplant",
"roles": [
"buyer"
]
}
],
"tag": [
"tender"
],
"tender": {
"aboveThreshold": true,
"awardPeriod": {
"endDate": "2026-03-30T23:59:59+01:00"
},
"contractTerms": {
"financialTerms": "30 days"
},
"coveredBy": [
"GPA"
],
"description": "NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.",
"documents": [
{
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
},
{
"datePublished": "2026-01-12T08:35:40Z",
"description": "Tender notice on Find a Tender",
"documentType": "tenderNotice",
"format": "text/html",
"id": "002096-2026",
"noticeType": "UK4",
"url": "https://www.find-tender.service.gov.uk/Notice/002096-2026"
}
],
"enquiryPeriod": {
"endDate": "2026-01-29T12:00:00Z"
},
"id": "C362396",
"items": [
{
"additionalClassifications": [
{
"description": "System quality assurance assessment and review services",
"id": "72225000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK11"
}
],
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"name": "Quality",
"numbers": [
{
"number": 30.0,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Social Value",
"numbers": [
{
"number": 10.0,
"weight": "percentageExact"
}
],
"type": "quality"
},
{
"name": "Price",
"numbers": [
{
"number": 60.0,
"weight": "percentageExact"
}
],
"type": "price"
}
]
},
"contractPeriod": {
"endDate": "2027-03-31T23:59:59+01:00",
"maxExtentDate": "2028-03-31T23:59:59+01:00",
"startDate": "2026-04-01T00:00:00+01:00"
},
"hasOptions": true,
"hasRenewal": true,
"id": "1",
"options": {
"description": "One (1) year optional extension"
},
"renewal": {
"description": "One (1) year optional extension"
},
"selectionCriteria": {
"criteria": [
{
"description": "As detailed in tender documents ( https://atamis-1928.my.site.com/ - C362396",
"type": "economic"
},
{
"description": "As detailed in tender documents ( https://atamis-1928.my.site.com/ - C362396. Must be EU Good Manufacturing Practice (GMP) Licenced.",
"type": "technical"
}
]
},
"status": "active",
"suitability": {
"sme": true
},
"value": {
"amount": 600000.0,
"amountGross": 660000.0,
"currency": "GBP"
}
}
],
"mainProcurementCategory": "services",
"procedure": {
"features": "It is the intention of the Authority to follow a two-stage process under this procedure as follows. However, the Authority retains the right to amend the stages if required throughout the process. This includes amending the number of stages or re-running any stage of the process.\nTender Stage 1:\n\u2022 Publish tender notice and tender documents \n\u2022 Receive tenders \n\u2022 Assess tenders to shortlist those to be invited to Stage 2\n\u2022 Notify shortlisted suppliers and invite to Stage 2 \nTender Stage 2:\n\u2022 Conduct presentations\nAward Stage: \n\u2022 Notify suppliers and issue assessment summaries \n\u2022 Publish contract award notice and commence standstill \n\u2022 Award contract"
},
"procurementMethod": "open",
"procurementMethodDetails": "Competitive flexible procedure",
"riskDetails": "Regulatory Changes: Future amendments to applicable laws, regulations, or industry standards may require adjustments to processes, compliance obligations, or service delivery models. Such changes could necessitate contract modifications to ensure continued compliance and operational effectiveness.\nAuthority Requirements: The Authority\u2019s operational priorities or service requirements may change during the contract term. These changes could affect contract usage volumes, scope, or delivery expectations, either positively (increased demand) or negatively (reduced demand). Where such changes occur, the contract may need to be varied to reflect revised requirements.",
"status": "active",
"submissionMethodDetails": "https://atamis-1928.my.site.com/",
"submissionTerms": {
"electronicSubmissionPolicy": "allowed",
"languages": [
"en"
]
},
"tenderPeriod": {
"endDate": "2026-02-09T12:00:00Z"
},
"title": "Next Generation Sequencing Testing (NGS)",
"value": {
"amount": 600000.0,
"amountGross": 660000.0,
"currency": "GBP"
}
}
}